All issues
Volume 51, Issue 12
Displaying 1-5 of 5 articles from this issue
- |<
- <
- 1
- >
- >|
-
[in Japanese]1977 Volume 51 Issue 12 Pages 595-598
Published: December 20, 1977
Released on J-STAGE: September 07, 2011
JOURNAL FREE ACCESSDownload PDF (451K) -
III Studies on a New Haemolysin Test Medium for Moraxella BovisIsamu INOUE, Taketoshi ARAI, Ichita YOSHIZAWA, Mituhiro YOKOZAWA1977 Volume 51 Issue 12 Pages 599-602
Published: December 20, 1977
Released on J-STAGE: September 07, 2011
JOURNAL FREE ACCESSThe authors studied on a new haemolysin test medium for M. bovis, and we obtained the following results.
1) HI agar medium showed the best function as basal medium for haemolysin test of M. bovis.
2) M. bovis showed the best haemolysis on HI agar medium containing 1% yeast extract at pH 8.0.
3) Ninety five percent of the strains of M. bovis isolated from clinical materials showed β-haemolysis, and other Moraxella species showed a-haemolysis or non-haemolysis on the new medium.View full abstractDownload PDF (439K) -
Isamu INOUE, Taketoshi ARAI, Ichita YOSHIZAWA, Mituhiro Yokozawa1977 Volume 51 Issue 12 Pages 603-607
Published: December 20, 1977
Released on J-STAGE: September 07, 2011
JOURNAL FREE ACCESSThe authors studied on toxic substances of Moraxella, and obtained the following results.
1) All of the strains of Moraxella tested did not produce coagulase or DNase.2) We found the production of fibrinolysin from M. bovis, M. lacunata and M. nonliquefaciens.
3) Hyaluronidase was produced from all of the strains of Moraxella tested, particularly M. osloensis.
4) Lecithinase was produced from all of the strains of Moraxella tested, particularly M. lacunata and M. nonliquefaciens.View full abstractDownload PDF (505K) -
Kenji WADA, Tsutomu HATANO, Shunkichi BABA1977 Volume 51 Issue 12 Pages 608-613
Published: December 20, 1977
Released on J-STAGE: September 07, 2011
JOURNAL FREE ACCESSFrom the laboratory and clinical investigations on T-1220, the following results were obtained.
1) Antibacterial activity of T-1220 was measured by the plate dilution method on 83 strains isolated from pathological materials in our clinic. The peak of MIC was 0.78μg/ml with sensitive Staphylococcus aureus (22strains). The antibacterial activity of T-1220 against Proteus species and Pseudomonas species was better than ABPC and CBPC.
2) T-1220 was prescribed clinically in 10 cases of ear, nose, throat and larynx infections, and effective rate was 66.7%.View full abstractDownload PDF (666K) -
1977 Volume 51 Issue 12 Pages 630-632
Published: December 20, 1977
Released on J-STAGE: September 07, 2011
JOURNAL FREE ACCESSDownload PDF (415K)
- |<
- <
- 1
- >
- >|